JP Morgan Maintains Overweight on Exponent, Lowers Price Target to $80

Benzinga Newsdesk www.benzinga.com Negative 86.6%

Neg 86.6% Neu 0% Pos 0%

JP Morgan analyst Tomohiko Sano maintains Exponent (NASDAQ:EXPO) with a Overweight and lowers the price target from $95 to $80.